Amir Fathi | Alisertib in combination with induction chemotherapy in high-risk patients with AML

Share it with your friends Like

Thanks! Share it with your friends!

Close

60th ASH Annual Meeting & Exposition, December 1-4 2018, San Diego, CA

Amir T. Fathi
Massachusetts General Hospital, Boston, US

Interview Topic (English): Alisertib in combination with induction chemotherapy in high-risk patients with AML

For more information and expert opinions in Acute Myeloid Leukemia (AML), please visit: www.amlglobalportal.com

Comments

Write a comment